Abstract: A solid dosage form for oral transmucosal delivery of an active pharmaceutical ingredient (API) is disclosed. Also provided are methods of treating a disease with the solid dosage form.
Abstract: A novel unit dosage form for oral transmucoal delivery of an active pharmaceutical ingredient (API). The dosage form contains a permeation enhancer that promotes fast absorption, rapid onset of action, and overall high bio availability for the API.